Advisors Asset Management Inc. Acquires 1,757 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Advisors Asset Management Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 15,997 shares of the medical equipment provider’s stock after buying an additional 1,757 shares during the quarter. Advisors Asset Management Inc.’s holdings in Intuitive Surgical were worth $8,350,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the business. M.E. Allison & CO. Inc. bought a new stake in Intuitive Surgical during the 4th quarter valued at $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical during the fourth quarter valued at approximately $82,517,000. Sycomore Asset Management increased its holdings in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares during the period. Exome Asset Management LLC lifted its stake in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its holdings in Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 1.0 %

Shares of NASDAQ:ISRG opened at $483.95 on Wednesday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The stock’s 50-day moving average price is $565.43 and its 200-day moving average price is $531.90. The stock has a market capitalization of $172.37 billion, a P/E ratio of 75.50, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. UBS Group upped their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Royal Bank of Canada upped their target price on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Bernstein Bank boosted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. BTIG Research upped their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Finally, Evercore ISI raised their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 in the last ninety days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.